MENU
JUNS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Jupiter Neurosciences (JUNS) Ownership - Who owns Jupiter Neurosciences?
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
55.38M
P/E Ratio
N/A
Total Cash
1.88M
Projected Growth
N/A
Total Debt
192.86K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.05
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
JUNS
Capitalization
55.4M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
1.88M
Total Cash/Share
0.05
Total Debt
193K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
1.34M
P/B Ratio
41.32
Cash Flow
N/A
Earnings
-0.18
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3.48K
Current Ratio
1.07
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-5.77M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-287.49
Shares Held By Institutions
175K
Shares Outstanding - Current
34.8M
Total Liabilities
2.63M
Total Volume MTD
N/A
Value
-1
Gain YTD
-85.140
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. JUNS showed earnings on September 03, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information